1. Home
  2. TSE vs ICCC Comparison

TSE vs ICCC Comparison

Compare TSE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.56

Market Cap

68.0M

Sector

Industrials

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$6.06

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSE
ICCC
Founded
2010
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.0M
55.5M
IPO Year
2014
1987

Fundamental Metrics

Financial Performance
Metric
TSE
ICCC
Price
$0.56
$6.06
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
671.3K
22.4K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
4.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$3,133,800,000.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
N/A
$24.05
Revenue Growth
N/A
16.49
52 Week Low
$0.60
$4.28
52 Week High
$6.85
$7.60

Technical Indicators

Market Signals
Indicator
TSE
ICCC
Relative Strength Index (RSI) 26.08 60.10
Support Level $0.60 $4.72
Resistance Level $0.76 $5.36
Average True Range (ATR) 0.08 0.34
MACD 0.01 0.17
Stochastic Oscillator 0.60 88.46

Price Performance

Historical Comparison
TSE
ICCC

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: